BRIEFING

 〈1771〉 Ophthalmic Products—Performance Tests. This proposal is based on the version of the chapter official as of May 1, 2016. This chapter title is being updated to Ophthalmic Products—General Considerations 〈1771〉 and being revised to include recommended techniques for evaluation of quality and performance attributes of ophthalmic drug products during development. The updated chapter still includes recommendations for dissolution testing but also includes recommendations for sterilization methods, container–closure system evaluation (including drop size, resuspendability, and leachables and extractables), and simulated-use studies.

 Additionally, minor editorial changes have been made to update the chapter to current USP style.

 (GCDF: M. Marques)

 Case ID—SUB-2482